ClinicalThought


Share

Program Content

Activities

  • Challenges for HER2neg EBC
    Current Challenges With Individualizing Therapy for HER2-Negative Early-Stage Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 03, 2024

    Expires: April 02, 2025

  • Dilemmas in HER2neg EBC
    Clinical Dilemmas When Selecting Adjuvant Therapy for HER2-Negative Early-Stage Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 19, 2024

    Expires: July 18, 2025

Faculty

cover img faculity

Tanya Gupta, MD

Palo Alto Medical Foundation
Palo Alto, California

cover img faculity

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner